AR009756A1 - Composicion farmaceutica para usar en el tratamiento de enfermedades inducidas por el virus sincitial respiratorio - Google Patents
Composicion farmaceutica para usar en el tratamiento de enfermedades inducidas por el virus sincitial respiratorioInfo
- Publication number
- AR009756A1 AR009756A1 ARP970104166A ARP970104166A AR009756A1 AR 009756 A1 AR009756 A1 AR 009756A1 AR P970104166 A ARP970104166 A AR P970104166A AR P970104166 A ARP970104166 A AR P970104166A AR 009756 A1 AR009756 A1 AR 009756A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- virus
- respiratory
- sincitial
- treatment
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
- 108090001007 Interleukin-8 Proteins 0.000 abstract 1
- 206010035737 Pneumonia viral Diseases 0.000 abstract 1
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
- 208000009421 viral pneumonia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Una composicion farmacéutica que comprende una cantidad efectiva de al menos un compuesto seleccionado de entre el ácido 2-(2-(4-((4-clorofenil)fenilmetil)-1-piperazinil)etoxi)acético, un isomero optico individual o una sal farmacologicamenteac eptable del mismo, presenta un imortante efecto deinhibicion sobre la replicacion viral, además de un efecto inhibidor de las modificaciones celulares inducidas por el virus RSV (produccion de IL-8).Asimismo, este efecto farmacologico tienelugar sin que se produzca una disminucion del sistema inmunologico del paciente. Se observo la existenciade un efecto de proteccion inesperado producido al curar enfermedades tales como la bronquitis aguda o la neumonía viral, causadasen sere s humanos porel virus sincitial respiratorio, obtenido al administrar a la persona que necesite dicha terapia de la composicion farmacéutica mencionada más arriba.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96870114 | 1996-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR009756A1 true AR009756A1 (es) | 2000-05-03 |
Family
ID=8226163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970104166A AR009756A1 (es) | 1996-09-11 | 1997-09-11 | Composicion farmaceutica para usar en el tratamiento de enfermedades inducidas por el virus sincitial respiratorio |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6413970B1 (es) |
| EP (1) | EP0936909A1 (es) |
| JP (1) | JP2001500143A (es) |
| KR (1) | KR20000036025A (es) |
| CN (1) | CN1230116A (es) |
| AP (1) | AP9901474A0 (es) |
| AR (1) | AR009756A1 (es) |
| AU (1) | AU717354B2 (es) |
| BR (1) | BR9712033A (es) |
| CA (1) | CA2265542A1 (es) |
| CZ (1) | CZ83099A3 (es) |
| EA (1) | EA001262B1 (es) |
| HU (1) | HUP9904173A3 (es) |
| ID (1) | ID21369A (es) |
| IL (1) | IL128351A0 (es) |
| NO (1) | NO991164D0 (es) |
| NZ (1) | NZ334571A (es) |
| OA (1) | OA10993A (es) |
| PE (1) | PE107598A1 (es) |
| PL (1) | PL332316A1 (es) |
| TR (1) | TR199900523T2 (es) |
| WO (1) | WO1998010764A1 (es) |
| ZA (1) | ZA977874B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2324242A (en) * | 1997-04-18 | 1998-10-21 | Atindra Nath Chakrabarty | Medicaments for treating viral infections |
| BR0011997A (pt) | 1999-06-28 | 2002-03-05 | Janssen Pharmaceutica Nv | Inibidores da replicação do vìrus sincicial respiratório |
| CN1210275C (zh) | 1999-06-28 | 2005-07-13 | 詹森药业有限公司 | 呼吸道合胞病毒复制抑制剂 |
| EP1418175A1 (en) | 1999-06-28 | 2004-05-12 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
| ATE386526T1 (de) * | 2002-07-02 | 2008-03-15 | Ucb Farchim Sa | Diarylmethylpiperazines als prophylaktische oder therapeutische mittel gegen virale myocarditis |
| WO2004050647A2 (en) * | 2002-12-04 | 2004-06-17 | Dr. Reddy's Laboratories Limited | Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof |
| KR100698400B1 (ko) | 2004-04-14 | 2007-03-23 | 이은주 | 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물 |
| CN102988346A (zh) * | 2012-11-19 | 2013-03-27 | 何晓涛 | Aphanamixoid A在抗呼吸道合胞病毒的药物中的应用 |
| CN103356650A (zh) * | 2013-07-04 | 2013-10-23 | 丁圣雨 | Chukrasone A在抗呼吸道合胞病毒的药物中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI75816C (fi) * | 1981-02-06 | 1988-08-08 | Ucb Sa | Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid. |
-
1997
- 1997-08-26 PE PE1997000761A patent/PE107598A1/es not_active Application Discontinuation
- 1997-09-02 ZA ZA977874A patent/ZA977874B/xx unknown
- 1997-09-08 EA EA199900226A patent/EA001262B1/ru not_active IP Right Cessation
- 1997-09-08 AU AU46213/97A patent/AU717354B2/en not_active Ceased
- 1997-09-08 IL IL12835197A patent/IL128351A0/xx unknown
- 1997-09-08 US US09/254,548 patent/US6413970B1/en not_active Expired - Fee Related
- 1997-09-08 NZ NZ334571A patent/NZ334571A/xx unknown
- 1997-09-08 KR KR1019997002003A patent/KR20000036025A/ko not_active Withdrawn
- 1997-09-08 WO PCT/EP1997/004859 patent/WO1998010764A1/en not_active Ceased
- 1997-09-08 BR BR9712033-2A patent/BR9712033A/pt not_active Application Discontinuation
- 1997-09-08 EP EP97944846A patent/EP0936909A1/en not_active Withdrawn
- 1997-09-08 PL PL97332316A patent/PL332316A1/xx unknown
- 1997-09-08 JP JP10513226A patent/JP2001500143A/ja active Pending
- 1997-09-08 ID IDW990073A patent/ID21369A/id unknown
- 1997-09-08 HU HU9904173A patent/HUP9904173A3/hu unknown
- 1997-09-08 CA CA002265542A patent/CA2265542A1/en not_active Abandoned
- 1997-09-08 CN CN97197831A patent/CN1230116A/zh active Pending
- 1997-09-08 TR TR1999/00523T patent/TR199900523T2/xx unknown
- 1997-09-08 AP APAP/P/1999/001474A patent/AP9901474A0/en unknown
- 1997-09-08 CZ CZ99830A patent/CZ83099A3/cs unknown
- 1997-09-11 AR ARP970104166A patent/AR009756A1/es not_active Application Discontinuation
-
1999
- 1999-03-10 NO NO991164A patent/NO991164D0/no not_active Application Discontinuation
- 1999-03-10 OA OA9900054A patent/OA10993A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998010764A1 (en) | 1998-03-19 |
| CZ83099A3 (cs) | 1999-06-16 |
| CN1230116A (zh) | 1999-09-29 |
| ID21369A (id) | 1999-05-27 |
| BR9712033A (pt) | 2000-01-18 |
| TR199900523T2 (xx) | 1999-05-21 |
| PE107598A1 (es) | 1999-01-29 |
| KR20000036025A (ko) | 2000-06-26 |
| AU717354B2 (en) | 2000-03-23 |
| EP0936909A1 (en) | 1999-08-25 |
| NO991164L (no) | 1999-03-10 |
| AP9901474A0 (en) | 1999-03-31 |
| HUP9904173A2 (hu) | 2000-05-28 |
| IL128351A0 (en) | 2000-01-31 |
| HUP9904173A3 (en) | 2001-04-28 |
| EA199900226A1 (ru) | 1999-08-26 |
| NZ334571A (en) | 2000-10-27 |
| US6413970B1 (en) | 2002-07-02 |
| PL332316A1 (en) | 1999-08-30 |
| JP2001500143A (ja) | 2001-01-09 |
| AU4621397A (en) | 1998-04-02 |
| ZA977874B (en) | 1999-03-02 |
| OA10993A (fr) | 2003-03-04 |
| NO991164D0 (no) | 1999-03-10 |
| EA001262B1 (ru) | 2000-12-25 |
| CA2265542A1 (en) | 1998-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Laver et al. | Disarming flu viruses | |
| AR022939A1 (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparacion | |
| UY27092A1 (es) | Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen | |
| CY1105120T1 (el) | Η αντιμετωπιση αναπνευστικων νοσων | |
| NO20032111L (no) | Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter | |
| AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
| AR020803A1 (es) | Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento | |
| BR0307050A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal | |
| AR021074A1 (es) | COMPOSICIoN FARMACÉUTICA DE MOXIFLOXACINA, PROCEDIMIENTO PARA SU PRODUCCIoN, Y USO DE DICHA COMPOSICIoN PARA PREPARAR UN MEDICAMENTO ANTIBACTERIANO. | |
| AR039164A1 (es) | Sales de venlafaxina de baja solubilidad en agua | |
| AR009756A1 (es) | Composicion farmaceutica para usar en el tratamiento de enfermedades inducidas por el virus sincitial respiratorio | |
| PE11399A1 (es) | Combinacion de loratadina y un descongestionante para el tratamiento del asma | |
| NO20023486L (no) | Forbindelser av pyrroltypen, perapater inneholdende forbindelser samt deres anvendelse for behandling av cancer- ogvirale sykdommer | |
| ATE339198T1 (de) | Verwendung von 2-amino-2-(2-(4- octylphenyl)ethyl)propane-1,3-diol zur prävention oder behandlung viraler myocarditis | |
| BR0111933A (pt) | Uso de ácido pamÈico ou um de seus derivados, ou um de seus análogos, para a preparação de um medicamento para o tratamento de doenças caracterizadas por depósitos de agregados amilõides | |
| BR9809234A (pt) | Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo. | |
| UY26067A1 (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimiento | |
| BR0213037A (pt) | Derivados de pirimidina | |
| BRPI0409380A (pt) | composições farmacêuticas | |
| BR0310061A (pt) | Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições | |
| CY1107465T1 (el) | Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων | |
| ATE170076T1 (de) | Angiotensin ii-antagonisten zur behandlung von viralen erkrankungen | |
| AR029666A1 (es) | Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina | |
| BR9909471A (pt) | Formas vi e cristalina de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, composição, composto, uso de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, e, processos para o tratamento ou profilaxia de uma infecção viral em ser humano e para a produção de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol | |
| MX9300638A (es) | Derivados del acido aminobenzoico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |